Mitochondrial dynamics as a pathobiological mediator of clonal myeloid disorders
Cancer Science · 2023
DOI: 10.1111/cas.15810 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Science, 2023. Verfasst von Yoshihiro Hayashi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Oncology, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Myeloid malignancies, including myelodysplastic syndromes and acute myeloid leukemia, are a group of clonal hematopoietic stem cell (HSC) diseases. The incidence increases with global population aging. Genome sequencing uncovered mutational profiles in patients with myeloid malignancies and healthy elderly individuals. However, the molecular and cellular basis of disease development remains unclear. Accumulating evidence shows mitochondrial involvement in the pathogenesis of myeloid malignancies, aging‐related HSC phenotypes, and clonal hematopoiesis. Mitochondria are dynamic organelles that continuously undergo fission and fusion processes to maintain their function, integrity, and activity. Mitochondria could be a hub of various biological processes that underlie cellular and systemic homeostasis. Thus, mitochondrial dysfunction could directly lead to the disruption of cellular homeostasis and the development of various disorders, including cancer. Notably, emerging data have revealed that mitochondria dynamics also primarily affect not only mitochondrial function and activity but also cellular homeostasis, the aging process, and tumorigenesis. Here, by focusing on mitochondrial dynamics, we highlight the current understanding of mitochondrial roles as a pathobiological mediator of myeloid malignancies and aging‐related clonal hematopoiesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Oncology, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
ORCID-Profile: Yoshihiro Hayashi, Hironori Harada
Zitieren
APA
Hayashi, Y., & Harada, H. (2023). Mitochondrial dynamics as a pathobiological mediator of clonal myeloid disorders. Cancer Science. https://doi.org/10.1111/cas.15810
Vancouver
Hayashi Y, Harada H. Mitochondrial dynamics as a pathobiological mediator of clonal myeloid disorders. Cancer Science. 2023. doi:10.1111/cas.15810
BibTeX
@article{Hayashi2023,
author = {Hayashi, Yoshihiro and Harada, Hironori},
title = {Mitochondrial dynamics as a pathobiological mediator of clonal myeloid disorders},
journal = {Cancer Science},
year = {2023},
doi = {10.1111/cas.15810}
}
EUVIMED